Kairos Pharma, Ltd. KAPA
KAPA
Kairos Pharma, Ltd. LIXT
Lixte Biotechnology Holdings, Inc. PTHS
Pelthos Therapeutics Inc. LEXX
Lexaria Bioscience Corp. CASI
CASI Pharmaceuticals, Inc. ALLR
Allarity Therapeutics, Inc. CLSD
Clearside Biomedical, Inc. CING
Cingulate Inc. BCTX
BriaCell Therapeutics Corp. ENTO
Entero Therapeutics, Inc.
Kairos Pharma, Ltd. LIXT
Lixte Biotechnology Holdings, Inc. PTHS
Pelthos Therapeutics Inc. LEXX
Lexaria Bioscience Corp. CASI
CASI Pharmaceuticals, Inc. ALLR
Allarity Therapeutics, Inc. CLSD
Clearside Biomedical, Inc. CING
Cingulate Inc. BCTX
BriaCell Therapeutics Corp. ENTO
Entero Therapeutics, Inc.
Performance
| Periode | KAPA | LIXT | PTHS | LEXX | CASI | ALLR | CLSD | CING | BCTX | ENTO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 17.62 % | 419.90 % | 124.58 % | -35.93 % | -41.08 % | 6.06 % | -92.06 % | -1.70 % | -72.39 % | 89.21 % |
| YTD | -51.49 % | 82.43 % | 124.58 % | -75.65 % | -74.30 % | -5.41 % | -93.02 % | -20.78 % | -90.70 % | 35.57 % |
| 1Y | -55.56 % | 104.55 % | 124.58 % | -76.37 % | -75.05 % | -2.78 % | -92.83 % | -16.18 % | -89.93 % | 39.15 % |
| 3Y | -71.45 % | -17.35 % | 124.58 % | -76.27 % | -48.24 % | -100.00 % | -93.99 % | -98.13 % | -98.74 % | -98.74 % |
| 5Y | -71.45 % | -88.33 % | 124.58 % | -87.50 % | -97.38 % | -100.00 % | -96.86 % | -99.62 % | -98.68 % | -100.00 % |
| 10Y | -71.45 % | -77.50 % | 124.58 % | -87.50 % | -92.10 % | -100.00 % | -99.08 % | -99.62 % | 5 226.92 % | -100.00 % |
| Depuis le début | -71.45 % | -99.85 % | 124.58 % | -87.50 % | -99.96 % | -100.00 % | -99.08 % | -99.62 % | 1 644.55 % | -100.00 % |